Skip to main content
RN

RNAimmune

Gaithersburg, United States
Last funding
$27.0M
Series AMar 2022

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

Backed bySirnaomicsTerra Magnum Capital PartnersRotating Boulder FundSmooth River

About RNAimmune

How much funding has RNAimmune raised?

RNAimmune has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are RNAimmune's investors?

RNAimmune's investors include Sirnaomics, Terra Magnum Capital Partners, Rotating Boulder Fund, Smooth River.

Where is RNAimmune headquartered?

RNAimmune is headquartered in Gaithersburg, United States.

What does RNAimmune do?

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

What stage is RNAimmune at?

RNAimmune is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"RNAimmune — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/rnaimmune. Accessed November 14, 2026.
APA
VCBacked. (2022). RNAimmune — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/rnaimmune
Wikipedia (cite web)
{{cite web |title=RNAimmune — Funding & Investors |url=https://www.vcbacked.co/company/rnaimmune |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at RNAimmune? Request a listing update

Founder contacts
m***@rnaimmune.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →